Regions Financial Corp Edwards Lifesciences Corp Transaction History

Regions Financial Corp

$13.8 Billion
Q3 2024

A detailed history of Regions Financial Corp transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Regions Financial Corp holds 38,723 shares of EW stock, worth $2.87 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

38,723

Previous 72,981 46.94%

Holding current value

$2.87 Million

Previous $6.74 Million 62.1%

% of portfolio

0.02%

Previous 0.05%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$59.7 - $93.78 $2.05 Million - $3.21 Million	-34,258 Reduced 46.94%	38,723 $2.56 Million
Q2 2024 Jul 31, 2024	SELL	$84.3 - $94.31 $156,123 - $174,662	-1,852 Reduced 2.47%	72,981 $6.74 Million
Q1 2024 Apr 23, 2024	SELL	$72.54 - $95.56 $273,911 - $360,834	-3,776 Reduced 4.8%	74,833 $7.15 Million
Q4 2023 Feb 06, 2024	SELL	$61.71 - $77.76 $180,933 - $227,992	-2,932 Reduced 3.6%	78,609 $5.99 Million
Q3 2023 Nov 01, 2023	SELL	$69.28 - $93.38 $373,211 - $503,038	-5,387 Reduced 6.2%	81,541 $5.65 Million
Q2 2023 Aug 09, 2023	SELL	$81.41 - $94.33 $379,452 - $439,672	-4,661 Reduced 5.09%	86,928 $8.2 Million
Q1 2023 May 12, 2023	BUY	$74.26 - $84.51 $180,600 - $205,528	2,432 Added 2.73%	91,589 $7.58 Million
Q4 2022 Feb 03, 2023	SELL	$68.3 - $87.44 $199,982 - $256,024	-2,928 Reduced 3.18%	89,157 $6.65 Million
Q3 2022 Nov 03, 2022	BUY	$82.37 - $107.29 $17,215 - $22,423	209 Added 0.23%	92,085 $7.61 Million
Q2 2022 Jul 25, 2022	SELL	$86.5 - $128.27 $327,316 - $485,373	-3,784 Reduced 3.96%	91,876 $8.74 Million
Q1 2022 Apr 25, 2022	BUY	$101.96 - $128.34 $262,954 - $330,988	2,579 Added 2.77%	95,660 $11.3 Million
Q4 2021 Jan 31, 2022	BUY	$106.37 - $130.68 $70,523 - $86,640	663 Added 0.72%	93,081 $12.1 Million
Q3 2021 Nov 04, 2021	SELL	$102.91 - $122.75 $251,100 - $299,510	-2,440 Reduced 2.57%	92,418 $10.5 Million
Q2 2021 Jul 27, 2021	SELL	$83.84 - $104.76 $238,944 - $298,566	-2,850 Reduced 2.92%	94,858 $9.82 Million
Q1 2021 Jun 02, 2021	BUY	$78.68 - $90.67 $329,275 - $379,453	4,185 Added 4.47%	97,708 $8.17 Million
Q4 2020 Feb 05, 2021	BUY	$71.69 - $91.23 $31,471 - $40,049	439 Added 0.47%	93,523 $8.53 Million
Q3 2020 Oct 15, 2020	BUY	$67.19 - $87.44 $497,206 - $647,056	7,400 Added 8.64%	93,084 $7.43 Million
Q2 2020 Jul 27, 2020	BUY	$57.54 - $76.95 $3.58 Million - $4.79 Million	62,280 Added 266.11%	85,684 $5.92 Million
Q1 2020 Apr 29, 2020	BUY	$52.41 - $81.0 $155,552 - $240,408	2,968 Added 14.52%	23,404 $4.42 Million
Q4 2019 Feb 03, 2020	SELL	$71.7 - $82.09 $147,056 - $168,366	-2,051 Reduced 9.12%	20,436 $4.77 Million
Q3 2019 Oct 24, 2019	SELL	$61.55 - $75.43 $8,001 - $9,805	-130 Reduced 0.57%	22,487 $4.95 Million
Q2 2019 Jul 19, 2019	SELL	$55.74 - $64.41 $39,909 - $46,117	-716 Reduced 3.07%	22,617 $4.18 Million
Q1 2019 Apr 19, 2019	SELL	$47.89 - $64.05 $431 - $576	-9 Reduced 0.04%	23,333 $4.46 Million
Q4 2018 Jan 28, 2019	BUY	$46.41 - $56.94 $11,695 - $14,348	252 Added 1.09%	23,342 $3.58 Million
Q3 2018 Oct 22, 2018	SELL	$45.7 - $58.03 $82,442 - $104,686	-1,804 Reduced 7.25%	23,090 $4.02 Million
Q2 2018 Jul 26, 2018	SELL	$42.45 - $51.3 $28,314 - $34,217	-667 Reduced 2.61%	24,894 $3.62 Million
Q1 2018 Apr 18, 2018	SELL	$37.19 - $47.45 $72,892 - $93,002	-1,960 Reduced 7.12%	25,561 $3.57 Million
Q4 2017 Jan 18, 2018	BUY	$33.79 - $39.39 $131,814 - $153,660	3,901 Added 16.52%	27,521 $3.1 Million
Q3 2017 Oct 23, 2017	BUY	$36.29 - $38.83 $857,169 - $917,164	23,620	23,620 $2.58 Million

Others Institutions Holding EW

# of Institutions

1,350

Shares Held

456M

Call Options Held

9.76M

Put Options Held

3.92M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $45.8B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Regions Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Regions Financial Corp with notifications on news.

Account

Regions Financial Corp Edwards Lifesciences Corp Transaction History